Monday, September 27, 2021
Home Tags COVID-19

COVID-19 Related News

UVA light treatment

Harnessing the benefits of UVA light treatment in COVID-19 patients

Following a first-in-human study which analysed the efficacy of UVA light treatment in COVID-19 patients, Health Europa spoke to Dr Ali Rezaie from the academic healthcare organisation, Cedars-Sinai, to find out more.
SARS-CoV-2 Delta variant

SARS-CoV-2 Delta variant causes twice the hospitalisations of Alpha

A novel study has revealed that the SARS-CoV-2 Delta variant may be the deadliest, demonstrating a two-fold increased risk of hospitalisation compared to the...
Point-of-care medicine: the future of rapid diagnostics in healthcare

Point-of-care medicine: the future of rapid diagnostics in healthcare

Abbott explores how point-of-care diagnostics will evolve in the wake of COVID-19, and showcases a new learning platform that aims to transform knowledge on rapid testing in primary care.
COVID-19 vaccine

Trial begins for world-first multivariant COVID-19 vaccine booster

A phase one trial for the world’s first multivariant COVID-19 booster vaccine has been launched in Manchester. Initiated by pharmaceutical company Gritstone, in partnership with...
ASAP Innovations: Pioneers of the personal protective equipment industry

ASAP Innovations: Pioneers of the personal protective equipment industry

As the COVID-19 crisis has evolved and the pandemic has just about taken its toll on almost every sector across the globe, those working...
biosensors

XPhyto Therapeutics’ biosensors: taking rapid testing to the next level

Testing for coronaviruses may soon take no more than a couple of minutes thanks to XPhyto’s enzyme-based biosensor diagnostic technology. A Canadian-headquartered life sciences company...
B lymphocytes

Enhancing vaccine design with B lymphocytes discovery

Findings from a research study of B lymphocytes – otherwise known as B cells – may aid in advancing the design of future vaccines. The...
new COVID vaccine

Defence Therapeutics’ new COVID vaccine achieves successful testing

Biotechnology experts Defence Therapeutics have sensationally announced that their new COVID vaccine has demonstrated effectiveness in a non-rodent model. The new COVID vaccine – called...
COVID-19 booster vaccines

Health experts believe COVID-19 booster vaccines are not yet required

A group of industry-leading health experts has concluded that COVID-19 booster vaccines are not yet needed to combat the pandemic. The international team of scientists,...
gout medication

Commonly prescribed gout medication found effective against COVID-19

A conventional gout medication that is utilised widely around the world has proven to be effective at combatting COVID-19, potentially adding a new weapon...
COVID-19 variants

COVID-19 variants will require infection control measures post-vaccination

Even after the implementation of widespread vaccination protocols, robust infection control measures will need to be enforced to prevent the spread of COVID-19 variants,...
mental-health-support

Frontline workers need better mental health support, experts say

Researchers have called for urgent improvements to mental health support for frontline healthcare workers in England. A team of psychiatrists and psychologists from University College...
Long-COVID-vaccine

Long COVID risk reduced by almost half after double vaccine dose

Receiving two COVID-19 vaccine doses reduces a person’s risk of experiencing long COVID by almost half, a new study has shown. Research led by King’s...
organ-transplants-COVID-19

Organ transplants fell by a third during first wave of COVID-19

The number of solid organ transplants performed globally dropped by 31% during the first wave of the COVID-19 pandemic, a new study has revealed. Research...
COVID-19-patients

Experts warn COVID-19 recovery could take longer than a year

Around one half of patients who were hospitalised with COVID-19 still experience health issues related to the virus after one year, a study has...
Pfizer-BioNTech-vaccine-children

Pfizer-BionNTech vaccine side effects mild to moderate in high-risk children

The side effects of the Pfizer-BionNTech vaccine in clinically vulnerable 12- to 15-year-olds are likely to be minimal, a study has shown. In a small...
pregnancy-COVID-pre-eclampsia

COVID-19 infection in pregnancy linked to higher risk of pre-eclampsia

Contracting COVID-19 during pregnancy can increase a woman’s risk of developing pre-eclampsia, researchers have demonstrated. A review of scientific literature by researchers in Brazil has...
breathing-device

Prototype breathing device created for COVID-19 patients in poor countries

Experts have developed a low-cost and easy-to-use prototype breathing device, designed specifically for poorer-resourced healthcare settings. Created in response to the surge of COVID-19 cases...
antibody

COVID-19 antibody surveillance programme launched in the UK

A new antibody surveillance scheme will be introduced in the UK to improve understanding of immunity against COVID-19 from vaccination and infection. Launching on Tuesday...
delta-variant

COVID-19 vaccines are still effective against Delta variant, study confirms

Two COVID-19 vaccine doses provide the most effective protection from the Delta variant in the UK, a new study has shown. Researchers from the University...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest